Testicular malignit tumors – are we in the end of the road?
Authors:
Jitka Abrahámová
Authors‘ workplace:
Onkologická klinika 1. LF UK a Thomayerovy nemocnice, Praha, přednosta doc. MUDr. Tomáš Büchler, Ph. D.
Published in:
Vnitř Lék 2014; 60(Suppl 2): 8-14
Category:
70th Birthday - prof. MUDr. Jiří Vorlíček, CSc.
Overview
Testicular germ cell tumors are currently the most curable cancer in adults. The 5-year survival is 95 %. In spite of this many patients come to physician in advanced stage of disease. The early diagnosis is an only way to improve outcomes in accordance to standardization, successfulness of complex diagnostic and therapy algorithm. Misdiag-nosis and errors of physicians are very rare nowadays however knowledge and oncology awareness of our young male population is inadequate. Health education targeted at young male population at risk has up to day large reserves.
Key words:
cisplatin – germ cell tumors – incidence – mortality – NSGCT – prevalence – seminoma
Sources
u autorky
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2014 Issue Suppl 2
-
All articles in this issue
- Testicular malignit tumors – are we in the end of the road?
- Patient follow-up after treatment of breast, colorectal and prostate cancer
- Differential diagnostics of hypereosinophilia
- Clinical evaluation of new drugs against orphan diseases in oncology – the current situation in Europe and in our country
- Palliative care and chronic heart failure
- Development and current utility of infobases in Czech cancer care
- About pain – otherwise
- New antibiotics: do we need new molecules or new strategies?
- Geriatric patient in oncology
- New aspects of impact of papillomavirus status in the therapy of head/neck cancer
- Ph-negative myeloproliferative diseases with thrombocythemia in the context of Thromboreductin® treatment, data from registry 2013
- Diabetes mellitus and malignancies
- Palliative medicine and the „good death“
- Internal Medicine
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Differential diagnostics of hypereosinophilia
- Palliative medicine and the „good death“
- Patient follow-up after treatment of breast, colorectal and prostate cancer
- Ph-negative myeloproliferative diseases with thrombocythemia in the context of Thromboreductin® treatment, data from registry 2013